Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,753 public trials 646 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity trial results

Completed

Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma

NCT02260492

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Oriel Investigative Site Goodyear, Arizona, United States

Oriel Investigative Site Tempe, Arizona, United States

Oriel Investigative Site Anaheim, California, United States

Oriel Investigative Site Los Angeles, California, United States

View all 47 locations

View Trial Details

Completed

GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese Subjects

NCT00955383

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Neuss, North Rhine-Westphalia, Germany

View Trial Details

Completed

Investigation of Novel Procedure for Methacholine Challenge Testing

NCT02965482

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Asthma Research Lab - University of Saskatchewan Saskatoon, Saskatchewan, Canada

View Trial Details

Completed

GSK2190915A - Bioavailability Study

NCT02224521

Conditions: Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Effect of a LAMA and a uLABA on the Methacholine Dose-response Curve

NCT02953041

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Asthma Research Lab, University of Saskatchewan Saskatoon, Saskatchewan, Canada

View Trial Details

Completed

Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler

NCT01213849

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)

NCT00777764

Conditions: Asthma, Bronchial Diseases, Healthy, +7 more
Locations: Not specified

View Trial Details

Completed

A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.

NCT01160003

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Berlin, Germany

View Trial Details

Completed

A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)

NCT00096954

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: Not specified

View Trial Details

Completed

A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)

NCT01669070

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: GSK Investigational Site Groningen, Netherlands

View Trial Details